摘要
目的评价盐酸文拉法辛缓释片治疗抑郁症的临床疗效。方法选取96例抑郁症患者，分成观察组和对照组。对照组给予帕罗西汀治疗。观察组给予盐酸文拉法辛缓释片治疗。结果治疗后，两组患者疗效相当，差异无统计学意义（P〉0．05）。治疗1、2周，观察组HAMD评分低于对照组，差异有统计学意义（P〈0．01）。治疗4．6周，观察组TESS评分优于对照组，差异有统计学意义（P〈0．01-0．05）。结论盐酸文拉法辛缓释片治疗抑郁症疗效佳，起效快，具有良好的安全性。
Objective To evaluate the clinical curative effect of venlafaxine hydrochloride sustained-release tablets in the treatment of depression. Methods 96 cases of depression patients were divided into the observation group and the control group. The control group was given paroxetine treatment, and the observation group was given venlafaxine hydrochloride sustained-release tablets treatment. Results After the treatment, the efficacy of the two groups was almost the same, the difference was not statistically significant（P〉0.05）. After the treatment of 1 or 2 weeks, the HAMD scores of the observation group were lower than those of the control group, the difference was statistically significant （P〈0.01）.Mter the treatment of 4 or 6 weeks, the TESS scores of the observation group were better than those of the control group, the difference was statistically significant （P〈0.01-.0.05）.Conclusion Venlafaxine hydrochloride sustained-release tablets have good curative effect, fast acting, and good safety in the treatment of depression.
出处
《中外医疗》
2014年第2期1-2,共2页
China & Foreign Medical Treatment
关键词
盐酸文拉法辛缓释片
抑郁症
帕罗西汀
Venlafaxine hydrochloride sustained-release tablets
Depression
Paroxetine
